EntryPoint Capital’s Arrowhead Research ARWR Stock Holding History

EntryPoint Capital’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,248	Closed	-$454K	–	787
2026 Q1	$454K	Buy	7,248 +2,287	+46%	+$145K	0.13%	288
2025 Q4	$329K	Buy	+4,961	New	+$243K	0.13%	320
2025 Q1	–	Sell	-12,375	Closed	-$233K	–	683
2024 Q4	$233K	Buy	+12,375	New	+$255K	0.1%	516

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EntryPoint Capital's ARWR Position: Q2 2026 in Review

EntryPoint Capital sold out of Arrowhead Research (ARWR) in Q2 2026, closing a stake of 7,248 shares — an estimated $454K sold.

EntryPoint Capital first reported a position in ARWR in Q4 2024 and held it in 3 quarters. The position peaked at $454K in Q1 2026. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

EntryPoint Capital reported no remaining Arrowhead Research position as of Q2 2026 after selling out during the quarter.
EntryPoint Capital sold 7,248 Arrowhead Research shares in Q2 2026, an estimated $454K.
EntryPoint Capital first reported a position in Arrowhead Research in Q4 2024 and held it in 3 quarters.
EntryPoint Capital's Arrowhead Research position peaked at $454K in Q1 2026.
500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.